Universal access to HIV/AIDS treatment for injecting drug users: Keeping the promise

International Journal of Drug Policy

Volumn 18, Issue 4, 2007, Pages 241-245

  Ball, Andrew Lee ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; BUPRENORPHINE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; LOPINAVIR; METHADONE; RITONAVIR; TENOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS PATIENT; BRAZIL; CLINICAL PROTOCOL; DEPRESSION; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DISEASE TRANSMISSION; DRUG COST; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; EARLY DIAGNOSIS; EDITORIAL; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTING DRUG USER; MENTAL HEALTH SERVICE; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; PATIENT COUNSELING; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; RISK REDUCTION; TREATMENT FAILURE; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DEVELOPING COUNTRIES; EVIDENCE-BASED MEDICINE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34547167954     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2007.07.001     Document Type: Editorial

References (31)

1. Aceijas C., Oppenheimer E., Stimson G.V., Ashcroft R.E., Matic S., and Hickman M. Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the 'Treating 3 million by 2005. Making it happen. The WHO strategy' ('3 by 5'). Addiction 101 9 (2006) 1246-1253
2. Bernays S., Rhodes T., Prodanovic A. (2007). HIV Treatment Access, Delivery and Uncertainty: A Qualitative Study in Serbia and in Montenegro, Belgrade/New York: United Nations Development Program.
3. Bobrova N., Sarang A., Raminta S., and Lezhentsev K. Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia. A regional overview. International Journal of Drug Policy 18 4 (2007) 306-311
4. Bruce R.D., Dvoryak S., Sylla L., and Altice F.L. HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine-programme description and policy implications. International Journal of Drug Policy 18 4 (2007) 326-328
5. Carrieri P., Villes V., Raffi F., Protopopescu C., Preau M., Salmon D., et al., The APROCO-COPILOTE ANRS CO-08 Study Group. Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8). International Journal of Drug Policy 18 4 (2007) 288-295
6. Central and Eastern European Harm Reduction Network (CEEHRN). Injecting drug users, HIV/AIDS treatment and primary care in Central and Eastern Europe and the Former Soviet Union (2002), CEEHRN, Vilnius
7. Chirac, J., Putin, V. V., Bush, G. W., Schröder, G., Koizumi, J., Berlusconi, S., et al. (2005). The Gleneagles Communiqué. Gleneagles: G8 Gleneagles 2005. http://www.fco.gov.uk/Files/kfile/PostG8_Gleneagles_Communique,0.pdf.
8. In: Curtis M. (Ed). Delivering HIV care and treatment for people who use drugs: Lessons from research and practice (2006), Open Society Institute, New York
9. Donoghoe M.C., Bollerup A.-M., Lazarus J.V., Nielsen S., and Matic S. Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002-2004. International Journal of Drug Policy 18 4 (2007) 271-280
10. European AIDS Treatment Group (2005). EATG Position paper on clinical research and drug users. URL: http://www.eatg.org/view_file.php?file_id=3
11. Gilks C., Crowley S., Ekpini R., Gove S., Perriens J., Souteyrand S., et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 368 (2006) 505-510
12. Global Price Reporting Mechanism (2007). URL: http://www.who.int/hiv/amds/GPRM%20summary%20April2007.pdf
13. Lert F., and Kazatchkine M. Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview. International Journal of Drug Policy 18 4 (2007) 255-261
14. Macalino G.E., Hogan J.W., Mitty J.A., Bazerman L.B., DeLong A.K., Loewenthal H., Caliendo A.M., and Flanigan T.P. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS 21 (2007) 1473-1477
15. Maher L., Coupland H., and Musson R. Scaling up HIV treatment, care and support for injecting drug users in Vietnam. International Journal of Drug Policy 18 4 (2007) 296-305
16. Muga R., Langhor K., Tor J., Sanvisens A., Serra I., Rey-Joly C., and Muñoz A. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-infected IDUs. Clinical Infectious Diseases 45 (2007) 370-376
17. Open Society Institute. Breaking down barriers: Lessons on providing HIV treatment to injection drug users (2004), Open Society Institute, New York
18. Open Society Institute. Harm Reduction Developments 2005: Countries with Injection-Driven HIV Epidemics (2006), Open Society Institute, New York
19. Sharma M., Singh R.R., Laishram P., Kumar B., Nanao H., Sharma C., and Ahmed T. Access, adherence, quality and impact of ART provision to current and ex-injecting drug users in Manipur (India): an initial assessment. International Journal of Drug Policy 18 4 (2007) 312-318
20. Spire B., Lucas G.M., and Carrieri M.P. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST): a review. International Journal of Drug Policy 18 4 (2007) 262-270
21. Sylla L., Bruce R.D., Kamarulzaman A., and Altice FL. Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. International Journal of Drug Policy 18 4 (2007) 319-325
22. Tyndall M., McNally M., Lai C., Zhang R., Wood E., Kerr T., et al. Directly observed therapy programs for antiretroviral treatment among injection drug users in Vancouver: Access, adherence and outcomes. International Journal of Drug Policy 18 4 (2007) 281-287
23. United Nations General Assembly. Resolution adopted by the General Assembly: 60/262. Political Declaration on HIV/AIDS (2006), United Nations, New York
24. Van Beek I. Case study: accessible primary health care-a foundation to improve health outcomes for people who inject drugs. International Journal of Drug Policy 18 4 (2007) 329-332
25. WHO (2005). The practice of charging user fees at the point of service delivery for HIV/AIDS treatment and care. (http://www.who.int/hiv/pub/advocacy/freeaccess/en).
26. WHO (2006). Progress on global access to HIV antiretroviral therapy: A report on "3 by 5" and beyond. March 2006. Geneva: WHO.
27. WHO Regional Office for Europe (2006). HIV/AIDS Protocols on Treatment and Care (including: HIV/AIDS Treatment and Care for Injecting Drug Users; Management of Hepatitis B and HIV Co-infection; and Management of Hepatitis C and HIV Co-infection). Copenhagen: WHO http://www.euro.who.int/eprise/main/WHO/Progs/SHA/treatment/20060801_1
28. WHO Regional Office for South-East Asia (2006). Guidelines for the Primary Health Care of Drug Users. New Delhi: WHO.
29. WHO and UNAIDS (2007). Guidance on provider-initiated HIV testing and counselling in health facilities. (http://www.who.int/hiv/who_pitc_guidelines.pdf).
30. WHO, UNAIDS and UNICEF (2007). Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector. Progress report, April 2007. Geneva: WHO.
31. Wolfe D. Paradoxes in antiretroviral treatment for injecting drug users: Access, adherence, and structural barriers in Asia and the former Soviet Union. International Journal of Drug Policy 18 4 (2007) 246-254